Variant report

Variant	esv3327113
Chromosome Location	chr19:51714613-51728152
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:138)
CpG islands
(count:184)
Chromatin interactive
region (count:2)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:138 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:51727399-51727801	K562	blood:	n/a	n/a
2	BATF	chr19:51722676-51722957	GM12878	blood:	n/a	n/a
3	BATF	chr19:51722668-51722952	GM12878	blood:	n/a	n/a
4	BCL11A	chr19:51722615-51723001	GM12878	blood:	n/a	n/a
5	BCL11A	chr19:51722682-51722908	GM12878	blood:	n/a	n/a
6	BCLAF1	chr19:51728143-51728388	GM12878	blood:	n/a	n/a
7	BHLHE40	chr19:51727561-51727802	K562	blood:	n/a	n/a
8	CBX3	chr19:51728005-51728512	K562	blood:	n/a	n/a
9	CBX3	chr19:51727137-51727908	K562	blood:	n/a	n/a
10	CCNT2	chr19:51727468-51727870	K562	blood:	n/a	n/a
11	CEBPD	chr19:51727280-51727802	K562	blood:	n/a	n/a
12	CEBPD	chr19:51727288-51727915	K562	blood:	n/a	n/a
13	CTCF	chr19:51715940-51716090	A549	lung:	n/a	n/a
14	CTCF	chr19:51718480-51718630	GM12864	blood:	n/a	n/a
15	CTCF	chr19:51714840-51714990	GM12869	blood:	n/a	n/a
16	ELF1	chr19:51728081-51728777	K562	blood:	n/a	n/a
17	ELF1	chr19:51727470-51727841	K562	blood:	n/a	n/a
18	ELF1	chr19:51728103-51728557	GM12878	blood:	n/a	n/a
19	EP300	chr19:51727297-51727902	K562	blood:	n/a	n/a
20	FOS	chr19:51725637-51725786	MCF10A-Er-Src	breast:	n/a	n/a
21	GABPA	chr19:51727365-51727785	K562	blood:	n/a	n/a
22	GABPA	chr19:51727898-51728769	K562	blood:	n/a	n/a
23	GABPA	chr19:51714243-51714669	HL-60	blood:	n/a	n/a
24	GABPA	chr19:51713963-51714624	K562	blood:	n/a	n/a
25	GABPA	chr19:51728107-51728442	Hela-S3	cervix:	n/a	n/a
26	GABPA	chr19:51728041-51728537	Hela-S3	cervix:	n/a	n/a
27	GABPA	chr19:51714229-51714699	HL-60	blood:	n/a	n/a
28	GABPA	chr19:51728076-51728555	K562	blood:	n/a	n/a
29	GABPA	chr19:51728129-51728420	GM12878	blood:	n/a	n/a
30	GATA2	chr19:51727398-51727830	K562	blood:	n/a	n/a
31	GATA2	chr19:51727362-51727738	K562	blood:	n/a	n/a
32	GATA2	chr19:51727263-51727850	K562	blood:	n/a	n/a
33	HCFC1	chr19:51727987-51728610	Hela-S3	cervix:	n/a	n/a
34	HDAC2	chr19:51727487-51727736	K562	blood:	n/a	n/a
35	HEY1	chr19:51727996-51728574	K562	blood:	n/a	n/a
36	HEY1	chr19:51727989-51728611	K562	blood:	n/a	n/a
37	IKZF1	chr19:51722644-51722997	GM12878	blood:	n/a	n/a
38	IRF1	chr19:51727203-51727215	K562	blood:	n/a	n/a
39	IRF1	chr19:51727384-51728453	K562	blood:	n/a	n/a
40	IRF1	chr19:51727456-51728506	K562	blood:	n/a	n/a
41	IRF1	chr19:51726649-51726786	K562	blood:	n/a	n/a
42	JUND	chr19:51727496-51727776	K562	blood:	n/a	n/a
43	MAFF	chr19:51727428-51727696	K562	blood:	n/a	n/a
44	MAFF	chr19:51725012-51725212	K562	blood:	n/a	n/a
45	MAX	chr19:51727429-51727918	K562	blood:	n/a	n/a
46	MAX	chr19:51727542-51727714	K562	blood:	n/a	n/a
47	MAX	chr19:51728008-51728669	K562	blood:	n/a	n/a
48	MAX	chr19:51728142-51728526	K562	blood:	n/a	n/a
49	MAX	chr19:51728148-51728444	K562	blood:	n/a	n/a
50	MAZ	chr19:51727598-51727839	K562	blood:	n/a	n/a

(count:184 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:51727921-51727971	MCF-7	breast:	n/a
2	chr19:51727921-51727971	MCF-7	breast:	n/a
3	chr19:51727921-51727971	HL-60	blood:	n/a
4	chr19:51727295-51727345	PrEC	prostate:	n/a
5	chr19:51727295-51727345	BJ	skin:	n/a
6	chr19:51727295-51727345	U87	brain:	n/a
7	chr19:51727921-51727971	NT2-D1	testis:	n/a
8	chr19:51727295-51727345	HNPCEpiC	eye:	n/a
9	chr19:51727798-51727848	HNPCEpiC	eye:	n/a
10	chr19:51727295-51727345	T-47D	breast:	n/a
11	chr19:51727295-51727345	HMEC	breast:	n/a
12	chr19:51727798-51727848	MCF-7	breast:	n/a
13	chr19:51727295-51727345	BE2_C	brain:	n/a
14	chr19:51727921-51727971	HPAEpiC	pulmonary alveolar:	n/a
15	chr19:51727295-51727345	GM12892	blood:	n/a
16	chr19:51727295-51727345	HepG2	liver:	n/a
17	chr19:51727921-51727971	U87	brain:	n/a
18	chr19:51727295-51727345	SK-N-SH	brain:	n/a
19	chr19:51727295-51727345	HCM	heart:	n/a
20	chr19:51727798-51727848	SK-N-SH	brain:	n/a
21	chr19:51727798-51727848	HCT-116	colon:	n/a
22	chr19:51727295-51727345	AG10803	skin:	n/a
23	chr19:51727921-51727971	GM12891	blood:	n/a
24	chr19:51727921-51727971	NH-A	brain:	n/a
25	chr19:51727295-51727345	HCT-116	colon:	n/a
26	chr19:51727921-51727971	ECC-1	luminal epithelium:	n/a
27	chr19:51727921-51727971	HNPCEpiC	eye:	n/a
28	chr19:51727921-51727971	AG09309	skin:	n/a
29	chr19:51727295-51727345	GM06990	blood:	n/a
30	chr19:51727798-51727848	GM12878	blood:	n/a
31	chr19:51727295-51727345	HAEpiC	amniotic membrane:	n/a
32	chr19:51727921-51727971	GM06990	blood:	n/a
33	chr19:51727295-51727345	AG04449	skin:	fetal
34	chr19:51727295-51727345	ProgFib	skin:	n/a
35	chr19:51727798-51727848	GM12892	blood:	n/a
36	chr19:51727921-51727971	HUVEC	blood vessel:	n/a
37	chr19:51727921-51727971	GM12892	blood:	n/a
38	chr19:51727798-51727848	HUVEC	blood vessel:	n/a
39	chr19:51727921-51727971	CMK	blood:	n/a
40	chr19:51727921-51727971	NHDF-neo	bronchial:	n/a
41	chr19:51727295-51727345	IMR90	lung:	fetal
42	chr19:51727798-51727848	HCF	heart:	n/a
43	chr19:51727798-51727848	SAEC	small airway:	n/a
44	chr19:51727921-51727971	Hepatocyte	liver:	n/a
45	chr19:51727921-51727971	Jurkat	blood:	n/a
46	chr19:51727798-51727848	PFSK-1	brain:	n/a
47	chr19:51727295-51727345	NH-A	brain:	n/a
48	chr19:51727798-51727848	CMK	blood:	n/a
49	chr19:51727921-51727971	HCF	heart:	n/a
50	chr19:51727295-51727345	HCPEpiC	choroid plexus:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:51714707..51716374-chr19:51723614..51726003,2	K562	blood:
2	chr19:51714707..51716374-chr19:51723614..51726003,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CD33-1	chr19:51719157-51719361	XLOC_013124
2	lnc-CD33-1	chr19:51718770-51718813	XLOC_013124

No data

Variant related genes	Relation type
CD33	TF binding region
CD33	CpG island
GALNT3	miRNA target sites

Extended variants
information (count: 559 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:559 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116999688	chr19:51714619-51714620	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs1697556	chr19:51714625-51714626	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs201253537	chr19:51714628-51714629	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs376260652	chr19:51714637-51714638	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs188367791	chr19:51714682-51714683	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs572119510	chr19:51714683-51714684	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs1710397	chr19:51714691-51714692	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs199762462	chr19:51714698-51714699	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs1697555	chr19:51714719-51714720	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs563982842	chr19:51714731-51714732	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs200741649	chr19:51714733-51714734	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs531374722	chr19:51714741-51714742	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs908309	chr19:51714766-51714767	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs62623429	chr19:51714781-51714782	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs3987764	chr19:51714784-51714785	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs182622998	chr19:51714787-51714788	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs908308	chr19:51714805-51714806	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs565938749	chr19:51714869-51714870	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs539605668	chr19:51714875-51714876	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs140337493	chr19:51714902-51714903	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs570050468	chr19:51714917-51714918	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs537482101	chr19:51714933-51714934	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs555781446	chr19:51714962-51714963	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs150345857	chr19:51714967-51714968	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs111634534	chr19:51714969-51714970	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs535769672	chr19:51715001-51715002	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs567014697	chr19:51715010-51715011	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs554062195	chr19:51715028-51715029	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs572211357	chr19:51715035-51715036	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs545667763	chr19:51715046-51715047	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs61730559	chr19:51715064-51715065	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs534216719	chr19:51715073-51715074	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs564250940	chr19:51715103-51715104	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs61731260	chr19:51715120-51715121	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs576032806	chr19:51715130-51715131	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs543081088	chr19:51715147-51715148	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs191323317	chr19:51715173-51715174	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs61731261	chr19:51715176-51715177	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs547697765	chr19:51715193-51715194	ZNF genes & repeats Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs185624599	chr19:51715248-51715249	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs201203199	chr19:51715273-51715274	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs12971624	chr19:51715274-51715275	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs118007016	chr19:51715317-51715318	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs537164011	chr19:51715320-51715321	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs549470026	chr19:51715324-51715325	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs567667578	chr19:51715334-51715335	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs61730558	chr19:51715345-51715346	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs368070645	chr19:51715346-51715347	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs544224965	chr19:51715369-51715370	ZNF genes & repeats Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs565830777	chr19:51715427-51715428	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Adrenocortical carcinoma	18281524	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD

Chromatin state (count:83 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:51704800-51715000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:51713400-51715400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr19:51713400-51715800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
4	chr19:51713600-51715600	Enhancers	Primary hematopoietic stem cells	blood
5	chr19:51713800-51714800	Enhancers	Primary B cells from cord blood	blood
6	chr19:51714000-51715000	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
7	chr19:51714000-51715400	Enhancers	Spleen	Spleen
8	chr19:51714200-51715200	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
9	chr19:51714200-51715200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
10	chr19:51714200-51715200	Active TSS	Hela-S3	cervix
11	chr19:51714400-51714800	Active TSS	Brain Hippocampus Middle	brain
12	chr19:51714400-51715200	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
13	chr19:51714400-51715200	Enhancers	Lung	lung
14	chr19:51714600-51715400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr19:51714600-51716000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
16	chr19:51714800-51715400	Bivalent Enhancer	Placenta	Placenta
17	chr19:51715000-51715400	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
18	chr19:51715000-51717200	Enhancers	Primary neutrophils fromperipheralblood	blood
19	chr19:51715200-51715800	Enhancers	Primary hematopoietic stem cells short term culture	blood
20	chr19:51715200-51716800	Enhancers	Primary monocytes fromperipheralblood	blood
21	chr19:51715200-51719600	Weak transcription	Hela-S3	cervix
22	chr19:51715200-51721600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
23	chr19:51715400-51718600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr19:51715400-51729200	Weak transcription	Spleen	Spleen
25	chr19:51715800-51716400	Transcr. at gene 5' and 3'	Monocytes-CD14+_RO01746	blood
26	chr19:51715800-51718200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
27	chr19:51716000-51716200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
28	chr19:51716400-51716600	Genic enhancers	Monocytes-CD14+_RO01746	blood
29	chr19:51716600-51718000	Weak transcription	Monocytes-CD14+_RO01746	blood
30	chr19:51716800-51718200	Weak transcription	Primary monocytes fromperipheralblood	blood
31	chr19:51717200-51718400	Weak transcription	Primary neutrophils fromperipheralblood	blood
32	chr19:51718000-51721200	Strong transcription	Monocytes-CD14+_RO01746	blood
33	chr19:51718200-51718600	ZNF genes & repeats	Primary hematopoietic stem cells short term culture	blood
34	chr19:51718200-51721200	Strong transcription	Primary monocytes fromperipheralblood	blood
35	chr19:51718400-51719400	Strong transcription	Primary neutrophils fromperipheralblood	blood
36	chr19:51718600-51719200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr19:51718600-51719400	Strong transcription	Primary hematopoietic stem cells short term culture	blood
38	chr19:51719400-51721400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
39	chr19:51719400-51727600	Weak transcription	Primary neutrophils fromperipheralblood	blood
40	chr19:51721200-51722400	Weak transcription	Monocytes-CD14+_RO01746	blood
41	chr19:51721200-51726800	Weak transcription	Primary monocytes fromperipheralblood	blood
42	chr19:51721400-51721600	Enhancers	Primary hematopoietic stem cells short term culture	blood
43	chr19:51721600-51722000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
44	chr19:51721800-51722000	Enhancers	GM12878-XiMat	blood
45	chr19:51722000-51723400	Enhancers	Primary hematopoietic stem cells short term culture	blood
46	chr19:51722000-51723800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr19:51722200-51723600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr19:51722400-51722800	Enhancers	Monocytes-CD14+_RO01746	blood
49	chr19:51722800-51723400	Enhancers	Primary hematopoietic stem cells	blood
50	chr19:51722800-51723600	Weak transcription	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links